6505--Nuclear Medicine Radiopharmaceuticals (VA-26-00043023) WNY VAMC

The contract awarded to CARDINAL HEALTH 414, LLC under solicitation number 36C24226Q0604 is a firm-fixed-price agreement for the supply of nuclear medicine radiopharmaceuticals to the VA Western New York Healthcare System in Buffalo, NY, with a base period beginning July 1, 2026, and a potential performance period extending through June 30, 2030, inclusive of three one-year option periods. The contract value for the base year is $304,749.03, covering a wide range of radiopharmaceuticals including Tc-99m Sestamibi, F-18 FDG, Ga-68 Dotatate, I-131 NaI, and others, supplied in both unit dose and kit formats with annual quantities recurring in each option year. Deliveries must occur daily by 7:00 AM Eastern Time, with emergency deliveries required within two hours, including weekends and holidays, and all shipments must adhere to strict federal, state, and industry regulations from the NRC, FDA, DOT, DOE, and USP <797>, including proper shielding, labeling, and documentation. Packaging and labeling requirements mandate clear radioactive markings, barcoding via the VA’s Pinestar system, and inclusion of expiration times, preparation times, and activity levels, with unused kits expiring within two weeks eligible for no-cost replacement. The contractor must employ only licensed nuclear pharmacists or technologists under their direct supervision, maintain active NRC and FDA licenses, certify personnel are not on the HHS/OIG exclusion list, and comply fully with HIPAA for protected health information. Invoicing is required electronically through Tungsten Network, and the contractor is responsible for the safe disposal of radioactive waste. The Contracting Officer, Lorraine Hussain, holds primary responsibility for administration, with a designated Contracting Officer Representative responsible for technical inspection and acceptance at the Buffalo VA facility. Evaluation for award was based on best value through a comparative trade-off analysis rather than LPTA, with compliance to all technical, regulatory, and delivery requirements being paramount. Special provisions include immediate notification of regulatory issues, equipment recalls, or safety alerts, and mandatory participation in CPARS for performance evaluation. All contract terms are governed by FAR Part 12 for commercial items, incorporating commercial clauses with agency-specific VAAR alternates including personnel vetting, electronic payment submissions, security prohibitions, and an